Beijing Hotgen Biotech Co., Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 5,372.28 million compared to CNY 513.53 million a year ago. Net income was CNY 2,192.93 million compared to CNY 112.07 million a year ago.

Basic earnings per share from continuing operations was CNY 23.8243 compared to CNY 1.2162 a year ago.